A substance p agonist acts as an adjuvant to promote hapten-specific skin immunity.
Because substance p (SP) has been reported to be released from cutaneous sensory nerve endings after hapten application, we determined whether SP participates in contact hypersensitivity (CH) induction by using a SP agonist, GR73632 or delta-Aminovaleryl [Pro9, N-Me-Leu10]-substance P(7-11) and a SP antagonist, spantide I. When injected intradermally, SP agonist enhanced CH induced by conventional, but not optimal, sensitizing doses of hapten. By contrast, SP antagonist inhibited the induction of CH by optimal sensitizing doses of hapten. Moreover, SP agonist promoted CH induction and prevented tolerance when hapten was painted on skin exposed to acute, low-dose ultraviolet-B radiation. Intradermally injected SP agonist altered neither the density nor the morphology of epidermal Langerhans cells, implying that SP agonist enhanced the generation of hapten-specific immunogenic signals from the dermis. It is proposed that SP is a natural "adjuvant" that promotes the induction of CH within normal skin. Although exogenous SP agonist can prevent impaired CH and tolerance after ultraviolet-B radiation, the susceptibility of native SP to local neuropeptidases renders the neuropeptide unable to prevent the deleterious effects of ultraviolet-B radiation on cutaneous immunity.
Niizeki
H
H
The Schepens Eye Research Institute and Department of Dermatology, Harvard Medical School, Boston, Massachusetts, USA.
Kurimoto
I
I
Streilein
J W
JW
D000276:Adjuvants, Immunologic / Q000494:pharmacology*; D000818:Animals; D003877:Dermatitis, Contact / Q000209:etiology; D006241:Haptens / Q000276:immunology*; D007801:Langerhans Cells / Q000276:immunology; D051379:Mice; D008809:Mice, Inbred C3H; D012867:Skin / Q000276:immunology*; D013373:Substance P / Q000031:analogs & derivatives / Q000494:pharmacology / Q000502:physiology*; D014466:Ultraviolet Rays
D000276:Adjuvants, Immunologic; D006241:Haptens; D013373:Substance P; C042867:spantide